Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Kim

Showing results (371-380 of 533) with videos related to

Pageof 54
Sort By:
International Journal of Radiation Oncology, Biology, Physics|November 3, 2004
Tolerability of the Intergroup 0099 (INT 0099) regimen in locally advanced nasopharyngeal cancer with a focus on patients' nutritional statusMala Bahl, Lillian L Siu, Gregory R Pond, et al.
Biomedicines|July 27, 2024
Boosting Immunogenicity of a Recombinant <i>Mycobacterium smegmatis</i> Strain via Zinc-Dependent Ribosomal ProteinsShivani Singh, David Kanzin, Sarah Chavez, et al.
Biorxiv : the Preprint Server for Biology|January 3, 2024
Boosting bactericidal immunity of a recombinant <i>Mycobacterium smegmatis</i> strain via zinc-dependent ribosomal proteinsShivani Singh, David Kanzin, Sarah Chavez, et al.
Journal of Cell Science|August 16, 2017
Sub-mitochondrial localization of the genetic-tagged mitochondrial intermembrane space-bridging components Mic19, Mic60 and Sam50Mira Sastri, Manjula Darshi, Mason Mackey, et al.
Vaccine|July 25, 2006
Mycobacterium tuberculosis DeltaRD1 DeltapanCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosisVasan K Sambandamurthy, Steven C Derrick, Tsungda Hsu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 12, 2014
Early initiation of combination antiretroviral therapy in HIV-1-infected newborns can achieve sustained virologic suppression with low frequency of CD4+ T cells carrying HIV in peripheral bloodAri Bitnun, Lindy Samson, Tae-Wook Chun, et al.
Oral Oncology|January 3, 2016
Outcomes and prognostic factors for major salivary gland carcinoma following postoperative radiotherapyAli Hosni, Shao Hui Huang, David Goldstein, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 17, 2017
Phase I trial of radiation therapy and sorafenib in unresectable liver metastasesRebecca B Goody, Anthony M Brade, Lisa Wang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 7, 2020
Stereotactic body radiation therapy for hepatocellular carcinoma with Macrovascular invasionPablo Munoz-Schuffenegger, Aisling Barry, Eshetu G Atenafu, et al.
The Lancet. Oncology|December 20, 2011
Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trialNancy Y Lee, Qiang Zhang, David G Pfister, et al.
Pageof 54

Showing results (371-380 of 533) with videos related to

Sort By:
Pageof 54
International Journal of Radiation Oncology, Biology, Physics|November 3, 2004
Tolerability of the Intergroup 0099 (INT 0099) regimen in locally advanced nasopharyngeal cancer with a focus on patients' nutritional statusMala Bahl, Lillian L Siu, Gregory R Pond, et al.
Biomedicines|July 27, 2024
Boosting Immunogenicity of a Recombinant <i>Mycobacterium smegmatis</i> Strain via Zinc-Dependent Ribosomal ProteinsShivani Singh, David Kanzin, Sarah Chavez, et al.
Biorxiv : the Preprint Server for Biology|January 3, 2024
Boosting bactericidal immunity of a recombinant <i>Mycobacterium smegmatis</i> strain via zinc-dependent ribosomal proteinsShivani Singh, David Kanzin, Sarah Chavez, et al.
Journal of Cell Science|August 16, 2017
Sub-mitochondrial localization of the genetic-tagged mitochondrial intermembrane space-bridging components Mic19, Mic60 and Sam50Mira Sastri, Manjula Darshi, Mason Mackey, et al.
Vaccine|July 25, 2006
Mycobacterium tuberculosis DeltaRD1 DeltapanCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosisVasan K Sambandamurthy, Steven C Derrick, Tsungda Hsu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 12, 2014
Early initiation of combination antiretroviral therapy in HIV-1-infected newborns can achieve sustained virologic suppression with low frequency of CD4+ T cells carrying HIV in peripheral bloodAri Bitnun, Lindy Samson, Tae-Wook Chun, et al.
Oral Oncology|January 3, 2016
Outcomes and prognostic factors for major salivary gland carcinoma following postoperative radiotherapyAli Hosni, Shao Hui Huang, David Goldstein, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 17, 2017
Phase I trial of radiation therapy and sorafenib in unresectable liver metastasesRebecca B Goody, Anthony M Brade, Lisa Wang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 7, 2020
Stereotactic body radiation therapy for hepatocellular carcinoma with Macrovascular invasionPablo Munoz-Schuffenegger, Aisling Barry, Eshetu G Atenafu, et al.
The Lancet. Oncology|December 20, 2011
Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trialNancy Y Lee, Qiang Zhang, David G Pfister, et al.
Pageof 54